Byondis
Joan van der Eerden has extensive experience in executive assistance, spanning several decades in the pharmaceutical and biopharmaceutical industries. Currently serving as Executive Assistant to the Board at Byondis since September 2011, Joan previously held the position of Executive Assistant at Synthon Biopharmaceuticals, where support was provided to Board members. Prior experience includes roles as Executive Assistant at MSD, and as Executive Assistant at Schering-Plough Research Institute. Joan's career began as a Management Assistant at Diosynth and continued for 26 years at Organon, contributing valuable expertise in administrative support to high-level executives throughout the professional journey.
This person is not in any teams
This person is not in any offices
Byondis
1 followers
With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs. Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves: • Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications • Site-specific conjugation technology • Monoclonal antibodies (mAbs) • Highly selective, disease-targeting small molecules The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.